Advertisement
AVR vs CV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVR is a StrongBuy and CV is a Buy.
AVR's Stochastic Oscillator sits in oversold zone for 22 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +3.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVR advanced for three days, in 91 of 102 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AVR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for AVR entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.326) is normal, around the industry mean (2.874). P/E Ratio (-3.077) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (238.095) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. AVR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Momentum Indicator for CV turns positive, indicating new upward trend
CV saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned positive. In 22 of the 24 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CV just turned positive on October 19, 2026. Looking at past instances where CV's MACD turned positive, the stock continued to rise in 7 of 10 cases over the following month. The odds of a continued upward trend are 70%.
CV moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CV crossed bullishly above the 50-day moving average on September 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 3 of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +1.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where CV advanced for three days, in 61 of 70 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
CV broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CV's P/B Ratio (27.482) is slightly higher than the industry average of (2.874). P/E Ratio (-6.103) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (21.598) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
| AVR | CV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 80% | N/A |
| Stochastic ODDS (%) | 4 days ago 90% | 1 day ago 90% |
| Momentum ODDS (%) | N/A | 1 day ago 90% |
| MACD ODDS (%) | N/A | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 88% |
| Advances ODDS (%) | 3 days ago 89% | 2 days ago 87% |
| Declines ODDS (%) | 1 day ago 87% | 8 days ago 82% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 64% | N/A |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AVR’s FA Score shows that 2 FA rating(s) are green while CV’s FA Score has 0 green FA rating(s).
- AVR’s FA Score: 2 green, 3 red.
- CV’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AVR’s TA Score shows that 4 TA indicator(s) are bullish while CV’s TA Score has 5 bullish TA indicator(s).
- AVR’s TA Score: 4 bullish, 2 bearish.
- CV’s TA Score: 5 bullish, 3 bearish.
Price Growth
AVR (@Medical/Nursing Services) experienced а -3.99% price change this week, while CV (@Medical/Nursing Services) price change was +2.41% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
AVR is expected to report earnings on Nov 11, 2026.
CV is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
AVR and
Correlation & Price change
A.I.dvisor tells us that AVR and MYO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVR and MYO's prices will move in lockstep.
| Ticker / NAME | Correlation To AVR | 1D Price Change % | ||
|---|---|---|---|---|
| AVR | 100% | -0.17% | ||
| MYO - AVR | 30% Poorly correlated | -3.17% | ||
| QSI - AVR | 29% Poorly correlated | -6.50% | ||
| CNMD - AVR | 27% Poorly correlated | +4.95% | ||
| TXG - AVR | 27% Poorly correlated | -7.73% | ||
| DCTH - AVR | 26% Poorly correlated | +0.34% | ||
More | ||||
CV and
Correlation & Price change
A.I.dvisor tells us that CV and QDEL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CV and QDEL's prices will move in lockstep.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBIB | 95.21 | 0.73 | +0.77% |
| JPMorgan BetaBuilders U.S. Treasury Bond 3-10 Year ETF (BBIB) | |||
| TDV | 102.88 | 0.17 | +0.16% |
| ProShares S&P Technology Dividend Aristocrats ETF (TDV) | |||
| XTAP | 46.97 | N/A | N/A |
| Innovator U.S. Equity Accelerated Plus ETF (XTAP) | |||
| PAUG | 46.78 | -0.25 | -0.53% |
| Innovator U.S. Equity Power Buffer ETF - August (PAUG) | |||
| IVV | 767.41 | -9.24 | -1.19% |
| iShares Core S&P 500 ETF (IVV) | |||